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Resuscitative endovascular balloon
occlusion of the aorta versus aortic cross
clamping among patients with critical
trauma: a nationwide cohort study in Japan
Toshikazu Abe1,2*, Masatoshi Uchida1, Isao Nagata1, Daizoh Saitoh3 and Nanako Tamiya1
Abstract
Background: Measures of aortic occlusion (AO) for resuscitation in patients with severe torso trauma remain
controversial. Our aim was to characterize the current use of resuscitative endovascular balloon occlusion of the
aorta (REBOA) and resuscitative open aortic cross-clamping (ACC), and to evaluate whether REBOA should be an
alternative method to resuscitative open ACC.
Methods: This study was a retrospective cohort study between 2004 and 2013 from a nationwide trauma registry
in Japan. Participants were selected who underwent either REBOA or ACC. Their characteristics, interventions, and
outcomes were analyzed to compare REBOA and ACC directly. The primary outcome was in-hospital mortality and
the secondary outcome was mortality in the emergency department. Logistic regression analysis was performed to
compare the outcomes between REBOA and ACC with adjustment for severity; 1:1 propensity score matching was
also performed.
Results: Of the 159,157 trauma patients, 903 were eligible based on the selection criteria. Overall, 405/607 patients
(67%) who had REBOA died compared to 210/233 patients (90%) who had ACC. Patients with REBOA had higher
revised trauma score (RTS) (mean ± SD, 5.2 ± 2.0 vs. 4.2 ± 2.2; P < 0.001) but higher Injury Severity Score (ISS) (median
(interquartile); 34 (25) vs. 34 (20); P < 0.001), and higher probability of survival (0.43 ± 0.36 vs. 0.27 ± 0.30; P < 0.001)
compared to those with ACC. REBOA had an odds ratio (OR) for in-hospital mortality of 0.309 (95% confidence
interval (CI) = 0.190–0.502) adjusting for trauma and injury severity score using a logistic regression model (n = 903).
Similar associations were observed adjusting for RTS (OR = 0.224; 95% CI = 0.129–0.700) or adjusting for ISS (OR,
0.188; 95% CI, 0.116 to 0.303). In the propensity score-matched cohort (n = 304), REBOA was associated with
lower mortality compared to ACC (OR, 0.261; 95% CI, 0.130 to 0.523). Patients with REBOA had less severe chest
complications than those with ACC (Abbreviated Injury Scale thorax, 3.8 ± 0.8 vs. 4.2 ± 0.8; P < 0.001), although
physiological severity and backgrounds were similar in this population.
Conclusions: Patients who underwent AO had a high mortality. REBOA might be a favorable alternative method to
resuscitative ACC for severe torso trauma although some indication bias could still remain. Further studies are needed
to elucidate optimal indications.
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Background
Bleeding control is a critical strategy in the management
of severe trauma patients. Aortic occlusion (AO) is a
standard initial procedure to control blood loss in severe
torso trauma patients which buys time for a more defini-
tive treatment. Open aortic cross-clamping (ACC), estab-
lished as just such a definitive approach, has been
traditionally accomplished via emergent thoracotomy
or as an initial step during laparotomy [1]. However,
ACC for resuscitation in critical trauma patients remains
controversial because of a very high mortality rate. In ac-
tuality, open ACC might suffer from a negative perception
because it might be used in patients already beyond
saving, thereby driving up the mortality rate. Recently,
resuscitative endovascular balloon occlusion of the aorta
(REBOA) has been used as an alternative method of ACC.
REBOA has been previously described as useful for
hemorrhagic shock in cases of ruptured abdominal aortic
aneurysm [2], gastrointestinal bleeding [3], and in postpar-
tum hemorrhage [4]. As they are useful in solving multiple
problems, endovascular approaches such as trans-catheter
arterial embolization (TAE) should become more widely
used in trauma settings. However, there is a dearth of clin-
ical reports with adequate sample size and situations on
which to base recommendations [5, 6]. There are a few re-
ports to show favorable outcomes of REBOA compared
with ACC [1] but no concrete indications of REBOA or
ACC efficacy exist at the time of this report. To this end,
our aim was to analyze the present situation of REBOA
and ACC usage with nationwide trauma registry data and
to then evaluate as to whether or not REBOA should be
deemed a preferential alternative to resuscitative ACC.
Methods
Study designs
We conducted a retrospective cohort study using registered
data from the Japan Trauma Data Bank (JTDB) to com-
pared characteristics and outcomes between REBOA
and ACC.
Data collection
Data were obtained from the JTDB, a nationwide trauma
registry established in 2003 and authorized and main-
tained by the Japanese Association for the Surgery of
Trauma and the Japanese Association for Acute Medicine
to improve and assure the quality of trauma care in Japan
[7]. During the study period, a total of 234 hospitals
including 95% of tertiary emergency medical centers in
Japan participated in the JTDB [7]. The JTDB collected
variables about patients and hospitals such as patient
demographics, comorbidities, injury type, mechanism,
vital signs, Abbreviated Injury Scale (AIS) score, Injury
Severity Score (ISS), pre-hospital treatment, in-hospital
procedures, and in-hospital and emergency department
(ED) mortality [7].
REBOA has recently found use as a general technique
across major emergency centers in Japan. Due to the
limitations of the JTDB as being a general, total trauma
registry and not a REBOA-specific database, we were un-
able to glean information on imaging, access, and balloon
zone placement specifics. Although details of REBOA in
those three areas depend mainly on local facilities and
expertise, in our specific cases REBOA access is typically
accomplished through a common femoral artery and the
balloon insertion follows a blind approach.
Patient selection
The study inclusion criteria were the presence of critical
trauma and reception of either REBOA or ACC. We ex-
cluded patients who had received both REBOA and
ACC. Also, we excluded subjects younger than 14 years
old or those with age data missing. Patients with car-
diopulmonary arrest on arrival at the ED (systolic blood
pressure of 0 mm Hg or data missing on arrival) or
with an AIS score of 6 (i.e., non-survivable injury) for
any region were also excluded. Figure 1 shows partici-
pant selection data from this study.
Study endpoints
The primary intervention was either REBOA or ACC.
Intervention strategies were solely dependent on the indi-
vidual decisions of ED physicians. The primary outcome
of this study was in-hospital mortality and the secondary
outcome was mortality in the ED.
Statistical analysis
To report the characteristics of participants, firstly we
used the Shapiro-Wilk test to identify normality of each
variable. However, there was some skew in almost all the
variables. We then decided whether to use the mean ±
standard deviation (SD) or median (interquartile range
(IQR)) for plot figures of each variable, depending on
the previous reporting style. To assess the independent
effects of REBOA compared with those of ACC, outcomes
were evaluated by analytical models—standard logistic
regression and a logistic regression incorporating the
results of propensity score matching. Since the number of
survivors was very small in this study population, we
chose a few covariates for the standard logistic regression
analyses. Within the standard logistic regression ana-
lyses, we conducted three adjustment models: a revised
trauma score (RTS)-adjusted model, an ISS-adjusted
model, and a trauma and injury severity score (TRISS)-
adjusted model. Together, these three standard logistic
regression models, coupled with a propensity score-
matched model, provide a robust method for statistically
reliable analysis.
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Propensity score
Because the use of REBOA or ACC was not randomly
assigned, a formal causal inference is not possible. There-
fore, a logistic regression analysis was used to estimate
propensity scores (PSs) to predict usage of REBOA or
ACC from the available predictors. These variables were
age, gender, mechanism of injury, cause of injury, trans-
port type, pre-hospital treatment, vital signs at ED, and
ISS, which would reflect patient wound severity. Treat-
ments after ED arrival (e.g., blood transfusion, cardio-
pulmonary resuscitation (CPR), operations) were not
included in the PS derivation process because they were
performed after usage of REBOA or ACC. Severity scoring
systems without ISS (e.g., RTS, TRISS) were not included
in the PS because in them were many of the same compo-
nents that had already been included in the PS, such as
vital signs. Propensity score matching extracted 1:1
matched pairs of subjects who received REBOA or ACC
based on an averaged PS. The absolute standardized
difference of variables for the PS estimation was used
to assess the match balance. An absolute standardized
difference of less than 0.2 was generally considered as
an acceptable match balance between the groups.
The two-sided significance level for all tests was P <
0.05. All analyses were performed using SPSS software,
version 21.0 (IBM, Armonk, NY, USA).
Results
A total of 159,157 trauma patients were registered in the
JTDB from 1 January 2004 to 31 December 2013. Of
these, 2032 patients with trauma were included in this
study because they received REBOA or ACC. Cases were
excluded if they received both REBOA and ACC (n = 90),
were below the cutoff age (n = 28), had age data missing
(n = 11), if they had already died (n = 922), had SBP data
missing (n = 58), or if they did not have a chance to
survive (i.e., AIS = 6) (n = 20). Thus, 903 patients were
included in the first round of calculations. After PS
matching, 304 patients were included in a second round
of analysis (Fig. 1).
Table 1 shows the characteristics of critical patients
with trauma who received either REBOA or ACC. The
mean age was 53.7 ± 21.2 years; 611/903 (67.7%) were
male. Blunt trauma was common (838/895; 93.6%). Mean
RTS was 4.94 ± 2.08. The RTS in REBOA cases was signifi-
cantly higher than in ACC cases. Median (interquartile)
ISS was 34 (20). ISS in REBOA cases were also more severe
than that in ACC cases. However, TRISS was higher in
REBOA cases than in ACC cases. Also, 153/636 (24%)
patients who were REBOA cases received TAE compared
to 18/267 (6.7%) who were ACC cases. Table 2 demon-
strates outcome comparisons between REBOA and ACC.
In-hospital mortality was 405/607 (67%) in REBOA and
210 /233 (90%) in ACC. ED mortality was 137/625 (22%)
in REBOA and 130/264 (49%) in ACC. Figure 2 shows a
comparison of the mortality between REBOA and ACC
(n = 903). Patients who underwent REBOA had a signifi-
cantly lower in-hospital mortality than those who under-
went ACC as shown by adjusted RTS (odds ratio (OR) =
0.224; 95% confidence interval (CI) = 0.129–0.700), ISS
(OR = 0.188; 95% CI = 0.116–0.303), or TRISS (OR =
0.309; 95% CI = 0.190–0.502), respectively. After PS
matching (n = 304), in-hospital mortality was 106/146
(73%) in REBOA and 122/134 (91%) in ACC, and ED
mortality was 24/149 (16%) in REBOA and 77/150
(51%) in ACC. Thus, mortality in the REBOA patients
was lower than that of ACC (OR = 0.261; 95% CI =
0.130–0.523 at discharge; OR = 0.182; 95% CI = 0.106–
0.313 at ED). Table 3 lists the baseline characteristics of
PS-matched patients (n = 304). There was no significant
difference between REBOA and ACC in RTS (mean ± SD;
4.8 ± 2.0 vs 4.7 ± 2.1; P = 0.631), ISS (median (interquartile);
Fig. 1 Flow chart of patients included in this study. AIS Abbreviated Injury Scale, ACC aortic cross-clamping, REBOA Resuscitative endovascular
balloon occlusion of the aorta, SBP systolic blood pressure
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Table 1 Characteristic of critical patients with trauma who had either REBOA or ACC
REBOA (n = 636) ACC (n = 267) P value Missing
Age (years) 52.5 ± 21.2 56.7 ± 21.1 0.007 0
Gender (male) 417/636 (66%) 194/267 (73%) 0.043 0
Onset year 0
2004–2008 218/636 (34%) 70/267 (26%)
2009–2013 418/636 (66%) 197/267 (74%)
Mechanism of injury (blunt vs. penetrating) 591/630 (94%) 247/265 (93%) 0.765 8
Cause of injury 0.754 31
Accident 429/618 (69%) 187/254 (74%)
Suicide 127/618 (21%) 44/254 (17%)
Assault 20/618 (32%) 6/254 (2.4%)
Workplace injuries 39/618 (6.3%) 16/254 (6.3%)
Other 1/618 (0.2%) 1/254 (0.4%)
Transport type 0.008 27
Ambulance 514/617 (83%) 194/259(75%)
Ambulance with physician 26/617 (4.2%) 24/259 (9.3%)
Helicopter with physician 73/617 (12%) 40/259 (15%)
Other 4/617 (0.6%) 1/259 (0.4%)
Vital signs at prehospital
SBP 101 (42) 105 (40) 0.42 358
HR 97 (37) 100 (43) 0.76 163
RR 24 (10) 25 (10) 0.445 232
Vital signs at emergency department
GCS value 10(12) 5(8) <0.001 21
SBP 89 (46) 87 (45) <0.001 0
HR 102 (36) 106 (52) 0.181 14
RR 25 (10) 24 (15) <0.001 99
RTS 5.2 ± 2.0 4.2 ± 2.2 <0.001 107
AIS 0
Head (n = 382) 3.6 ± 1.2 3.3 ± 1.1 0.101
Face (n = 167) 1.6 ± 0.7 1.8 ± 1.3 0.274
Neck (n = 14) 2.4 ± 1.3 1.5 ± 0.8 0.178
Thorax (n = 593) 3.8 ± 0.9 4.3 ± 1.1 <0.001
Abdomen and pelvis (n = 580) 3.6 ± 1.1 3.8 ± 1.5 0.143
Spine (n = 187) 2.5 ± 1.1 2.6 ± 0.9 0.959
Upper extremity (n = 209) 2.0 ± 0.6 2.1 ± 0.6 0.284
Lower extremity (n = 558) 3.7 ± 1.3 3.7 ± 1.2 0.702
Others (n = 39) 1.1 ± 0.4 1.2 ± 0.4 0.701
ISS 34 (25) 34 (20) <0.001 0
TRISS (probability of survival) 0.43 ± 0.36 0.27 ± 0.30 <0.001 12
Prehospital treatment
Airway protection maneuver 53/636 (8.3%) 41/267 (15%) 0.003 0
Intubation 44/636 (6.9%) 35/267 (13%) 0.004 0
Intravenous fluid 55/636 (8.6%) 25/267 (9.3%) 0.703 0
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34 (23) vs 36 (20), P = 0.341), and TRISS (mean ± SD;
0.45 ± 0.35 vs 0.39 ± 0.31, P = 0.115). However, the AIS
of the thorax was significantly lower in REBOA cases
than in ACC cases (3.8 ± 0.8 vs 4.2 ± 0.8, P < 0.001).
Thoracotomy at initial evaluation was also less frequent
in REBOA cases than in ACC cases. On the other hand,
patients with REBOA underwent angiography of the ab-
domen and pelvis, including TAE, more often than
those with ACC.
Discussion
Brief summary
This study investigated the current usage of REBOA and
ACC using a large, nationwide trauma database in Japan.
Mortality rates in patients requiring AO was discovered to
be very high but this is attributed to the usage of ACC on
patients who cannot be saved, skewing mortality out of favor
with ACC. We also analyzed outcomes for patients after
receiving either REBOA or ACC after adjusting for patient
trauma severity. Robust analyses of the adjusted data
showed that REBOA was associated with significantly re-
duced in-hospital mortality compared with ACC. However,
due to differences in associated procedures between REBOA
(e.g., increased need for angiography) and ACC (e.g., thora-
cotomy), there should be some consideration given to
choosing either intervention.
Comparison with previous studies
To our knowledge, our current study is one of the largest
cohort studies describing the use of REBOA [8]. REBOA
has recently found use as a general technique across major
emergency centers in Japan. The highest density of potential
REBOA patients is also seen at major trauma centers in
England and Wales, although the number of patients in
whom REBOA was utilized is small [9]. In fact, a review of
the potential use of REBOA in exsanguinating hemorrhage
cases in the US suggested that this new technique should
Table 1 Characteristic of critical patients with trauma who had either REBOA or ACC (Continued)
FAST 0.013 29
Positive 359/614 (59%) 133/260(51%)
Negative 233/614 (38%) 107/260 (41%)
Not conducted 22/614 (3.6%) 20/260 (7.7%)
Blood transfusion 542/636 (85%) 197/267 (74%) <0.001 0
CPR
ERT with CPR 71/636 (11%) 216/267 (81%) <0.001 0
Closed CPR 141/636 (22%) 92/267 (35%) <0.001 0
Operation at initial evaluation
Craniotomy 19/636 (3.0%) 1/267 (0.4%) 0.012 0
Craterization 17/636 (2.7%) 3/267 (1.2%) 0.215 0
Thoracotomy 70/636 (11%) 160/267 (60%) <0.001 0
Laparotomy 301/636 (47%) 99/267 (37%) 0.005 0
Angiography
Chest 29/636 (4.6%) 7/267 (2.6%) 0.196 0
Abdomen 156/636 (25%) 15/267 (5.6%) <0.001 0
Pelvis 151/636 (24%) 22/267 (8.2%) <0.001 0
TAE (all) 153/636 (24%) 18/267 (6.7%) <0.001 0
All categorical variables are shown as n (%); continuous variables are shown as mean ± standard deviation or median (interquartile)
ACC aortic cross-clamping, AIS Abbreviated Injury Score, CPR cardiopulmonary resuscitation, ERT Emergency resuscitative thoracotomy, FAST Focused assessment
with sonography for trauma, GCS Glasgow Coma Scale, HR heart rate, ISS Injury Severity Score, REBOA resuscitative endovascular balloon occlusion of the aorta, RR
Respiratory rate, RTS revised trauma score, SBP systolic blood pressure, TAE trans-catheter arterial embolization, TRISS trauma and injury severity score
Table 2 Outcome comparisons between REBOA and ACC
REBOA (n = 636) ACC (n = 267) P value
Disposition at discharge <0.001*
Died (in-hospital mortality) 405/607 (67%) 210/233 (90%)
Transferred 118/607 (19%) 11/233 (1.8%)
Home 83/607 (14%) 12/233 (2.0%)
Other 1/607 (0.1%) 0/233 (0.0%)
Disposition at ED <0.001*
Died (ED mortality) 137/625 (22%) 130/264 (49%)
CU admission 472/625 (76%) 129/264 (49%)
Ward admission 137/625 (22%) 4/264 (1.5%)
Other 5/625 (1.8%) 1/264 (0.4%)
The variables are shown as n (%)
ACC aortic cross clamping, ED emergency department, ICU intensive care unit,
REBOA resuscitative endovascular balloon occlusion of the aorta
*Chi-square test
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be thoroughly evaluated for broad use, but the literature
currently suffers from a dearth of human studies on REBOA
[10]. Although our observational study admittedly had some
selection bias, we feel that our results will nonetheless
become an important part of the foundation of literature
supporting the evaluation of global REBOA use.
Previous studies regarding REBOA usage have been
limited in size and scope, and have shown ambiguous
results. For example, although previous single-center co-
hort studies mentioned the utility of REBOA for massive
pelvic bleeding cases that could still be imaged by angiog-
raphy [5, 6], another large, retrospective cohort study
cautioned against REBOA usage for patients who had
emergency surgery or transcatheter embolization [7, 11].
Yet another single-center cohort study also reported on
the feasibility and safety of REBOA for a non-compressive
torso injury (pelvic fracture or hemoperitoneum) [12], but
contrasting studies also reported that REBOA usage was
associated with a higher mortality compared with non-
REBOA usage in JTDB [7, 11]. However, to objectively
evaluate these reports, a thorough knowledge of the
Japanese trauma care system is required. For example,
most Japanese emergency departments see few in-house
trauma surgeries, see fewer trauma cases overall, and mostly
deal with older patients and age-related maladies [13].
REBOA usage, in this context, may signal “last ditch” efforts
[11]. However, our results from the same database show an
incongruent outcome even though our study population
and comparisons are different. Previous reports have indi-
cated REBOA usage as a last resort in the most severe
trauma cases, but only one multicenter, prospective observa-
tional study (Aortic Occlusion for Resuscitation in Trauma
and Acute Care Surgery (AORTA) registry) [1] has looked
at direct comparisons with ACC, which is also used in the
most severe cases, and found REBOA to be beneficial. As
the severity criteria for both REBOA and ACC are similar, it
is reasonable to compare those outcomes directly and our
reports findings strengthen the conclusion of DuBose and
colleagues [1], and show a promising consistency in results.
Possible explanations and implications
AO was used on 2032 patients in our database. However,
799 patients with ACC were excluded from analysis
because of pre-hospital cardiopulmonary arrest. Although
we controlled for this in our study, the differences
between REBOA and ACC in general need more context
a
b
Fig. 2 Comparison of the mortality of REBOA versus ACC at discharge (a) and in the emergency department (ED) (b). *The covariates used to
estimate the propensity score were age, gender, mechanism of injury, cause of injury, transport type, prehospital treatment, vital signs at ED, and
Injury Severity Score (ISS). CI confidence interval, OR odds ratio, RTS revised trauma score, TRISS trauma and injury severity score
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Table 3 Baseline characteristic in propensity score-matched patients with severe trauma*
REBOA (n = 152) ACC (n = 152) SD P value Missing
Age (years) 52.8 ± 21.0 54.8 ± 22.1 0.09 0.421 0
Gender (male) 111/152 (73%) 101/152(66%) 0.14 0.261 0
Mechanism of injury (blunt vs. penetrating) 142/152 (93%) 141/152(93%) 0.03 1.000 0
Cause of injury 0.726 0
Accident 104 (68%) 109 (72%) 0.07
Suicide 28 (18%) 29 (19%) 0.02
Assault 6 (3.9%) 5 (3.3%) 0.04
Workplace injuries 14(92%) 9 (5.9%) 0.13
Other 0(0%) 0 (0%) 0.00
Transport type 0.542 0
Ambulance 124/152 (82%) 123/152(81%) 0.02
Ambulance with physician 6/152 (3.9%) 10/152 (6.6%) 0.12
Helicopter with physician 22/152 (15%) 19/152 (13%) 0.06
Other 0/152 (0%) 0/152(0%) 0.00
Vital signs at emergency department
GCS value 8(10) 8(10) 0.02 0.909 0
SBP 77.5 (64) 73.5 (64) 0.02 0.421 0
HR 108.0 (39) 109.5(52) 0.05 0.687 0
RR 25 (10) 24 (14) 0.08 0.499 0
RTS 4.8 ± 2.0 4.7 ± 2.1 0.631 0
ISS 34 (23) 36 (20) 0.11 0.341 0
TRISS (probability of survival) 0.45 ± 0.35 0.39 ± 0.31 0.115 0
Prehospital treatment
Airway protection maneuver 12/152 (7.9%) 11/152 (7.2%) 0.03 1.000 0
Intubation 9/152 (5.9%) 13/152 (8.6%) 0.10 0.508 0
Intravenous fluid 9/152 (5.9%) 14/152 (9.2%) 0.13 0.386 0
FAST 0.232 6
Positive 91/148 (62%) 78/150(52%)
Negative 52/148 (35%) 64/150(43%)
Not conducted 5/148 (3.4%) 8/150 (5.3%)
Blood transfusion 135/152 (89%) 121/152(80%) 0.04 0
AIS 0
Head 3.8 ± 1.3 3.4 ± 1.1 0.047
Face 1.7 ± 0.8 1.3 ± 0.5 0.036
Neck 1.3 ± 0.6 1.3 ± 0.5 0.846
Thorax 3.8 ± 0.8 4.2 ± 0.8 <0.001
Abdomen and pelvis 3.5 ± 1.0 3.8 ± 1.4 0.112
Spine 2.6 ± 0.9 2.6 ± 1.0 0.812
Upper extremity 2.1 ± 0.7 2.1 ± 0.6 0.833
Lower extremity 3.6 ± 1.4 3.6 ± 1.3 0.904
Other 1.0 ± 0.0 1.3 ± 0.5 0.172
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for accurate interpretation. In Japan, ACC currently seems
to be a preferred intervention tactic in non-survivable in-
jury cases and this differs from other countries, possibly
making Japanese ACC-related mortality rates non-indica-
tive of actual outcomes [1, 9, 13]. In addition, other patient
characteristics such as better Glasgow Coma Scale (GCS)
scores in cases where REBOA was used versus ACC cases
(with more severe GCS scores) may also skew results. This
raises the issue of snap decisions by ED physicians to
choose rapid thoracotomy over REBOA because ACC
would be more frequently chosen in cases with worse GCS
scores. A key point to keep in mind, however is that al-
though the probability of survival (TRISS) for REBOA was
better than that of ACC, it is still no guarantee of suc-
cess in severe cases (0.43 ± 0.36). Furthermore, REBOA
patients who die might count as preventable, but ACC
deaths with TRISS scores indicating unsurvivable injur-
ies (0.27 ± 0.30) would be counted as non-preventable.
This might not be seen as a negative even though the
mortality of ACC patients was very high (90%) and
might be related to more severe complications in the
thorax. These issues highlight the nuances necessary to
objectively interpret the data, as both REBOA and ACC
have complicating factors. Survival rates at ED of 78%
and 51% in REBOA and ACC, respectively, indicate
that both can serve a role in trauma treatment. However,
it is important to keep in mind that these procedures are
not panaceas; only 14% (83/607) of REBOA patients and
2.0% (12/233) of ACC patients could leave the hospital and
go home. This emphasizes the difficulty of AO in clinical
practice. This is especially evident in Japan as our mortality
was slightly higher than other countries [1, 9, 13]. As Japan’s
prevalence of penetrating trauma is quite low (6.4%),
survival probabilities may follow suit. However, taking into
consideration the variability in study populations and insti-
tutional skill, a general trend in the same direction can be
seen with our results versus those of other countries.
Trauma severity in ACC cases versus REBOA cases were
controlled for with sensitivity analyses as seen in Fig. 2, but
REBOA usage showed a clear survival benefit. PS matching
was also used to control for insufficiency of adjustment and
the tendency of results was the same among PS-matched
patients. We found that PS matching was one of the best
methods to control confounders in this prevalence and
mortality. Again, direct comparisons between REBOA and
ACC were conducted after PS matching because of current
interest in the possibility of shifting the ACC paradigm to
REBOA [10]. Table 3 shows the precision of our PS match-
ing methodology. However, covariate differences where
we did not use PS (although we did properly control
for physiological severity and backgrounds) unavoid-
ably resulted in an inability to match anatomical sever-
ity. This might be classified as an indication bias, but
we feel that our analysis shows the real utility of AO.
Taken together, we feel that these results should be made
part of the body of knowledge that physicians consult in the
decision tree of AO. Accordingly, REBOA would conceiv-
ably be used more often as a solo abdominal trauma option
even though there are no formal criteria for AO treatment
utility. Still, this does not necessarily mean that all AO cases
would shift from ACC to REBOA. In reality, choosing ACC
for severe abdominal trauma patients who present no chest
trauma is a difficult choice for ED physicians who may not
have enough thoracotomy experience. This is especially
Table 3 Baseline characteristic in propensity score-matched patients with severe trauma* (Continued)
Operation at initial evaluation
Craniotomy 3/152 (2.0%) 0/152(0%) 0.248 0
Craterization 4/152 (2.6%) 1/152 (0.7%) 0.371 0
Thoracotomy 20/152 (13%) 92/152(61%) <0.001 0
Laparotomy 79/152 (52%) 68/152(45%) 0.251 0
Angiography
Chest 2/152 (1.3%) 5/152 (3.3%) 0.448 0
Abdomen 27/152 (18%) 10/152 (6.6%) 0.004 0
Pelvis 33/152 (22%) 15/152 (9.9%) 0.007 0
TAE (all) 29/152 (19%) 11/152 (7.2%) 0.004 0
CPR
ERT with CPR 20/152 (13%) 125/152 (82%) <0.001 0
Closed CPR 33/152 (22%) 53/152(35%) 0.015 0
All categorical variables are shown as n (%); continuous variables are shown as mean ± standard deviation or median (interquartile)
ACC aortic cross-clamping, AIS Abbreviated Injury Score, CPR cardiopulmonary resuscitation, ERT Emergency resuscitative thoracotomy, FAST Focused assessment
with sonography for trauma, GCS Glasgow Coma Scale, HR heart rate, ISS Injury Severity Score, REBOA resuscitative endovascular balloon occlusion of the aorta, RR Respiratory rate,
RTS revised trauma score, SBP systolic blood pressure, SD standardized difference, TAE trans-catheter arterial embolization, TRISS trauma and injury severity score
*The covariates used to estimate the propensity score were age, gender, mechanism of injury, cause of injury, transport type, prehospital treatment, vital signs at
the emergency department, and ISS
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important because of recent reports on poor outcomes of
emergency thoracotomies after abdominal exsanguination,
adding to the reputation of ACC as a “last ditch” effort [13,
14]. However, to find the best position of an occlusion
balloon with a blind approach is next to impossible when
patients present with thoracic complications. This explains
the higher incidence of abdominal and pelvic angiography
in REBOA groups which we find to be an acceptable >trade-
off for accuracy in occlusion balloon positioning. We do not
doubt that REBOA will be applicable as a bridge to defini-
tive treatment in the ED, but indications and contraindica-
tions in the light of ACC must be further refined. Finally,
the most critical point to remember is that any method in-
ducing long-lasting ischemia to at least half or more of the
body has serious potential to harm the patient. To this end,
the decision to use REBOA or ACC should be part of a
robust clinical governance framework in order to ensure
high quality patient care and maximal survival chance [9].
Limitations
Potential limitations of this study should be acknowledged.
First, there remained some indication bias as previously
discussed, indicating caution when interpreting results for
clinical standpoints. However, we controlled for patient
background using logistic regression and PS-matched ana-
lysis, when possible, and found two key points in this study.
First, PS-matched analysis was one of the best methods for
comparison because there was a relatively small sample size
of survivors. Second, there was institutional bias although
covariates were carefully selected on the basis of the as-
sumption that none were affected directly by the interven-
tion. This assumption could be a potential weakness and
requires further study. With regard to mortality rates, a
population-based study in England and Wales showed only
major trauma centers had a high density of REBOA use
and their rate was smaller than ours [9]. We, on the other
hand, did not have institutional-level data, and therefore
we could not control for it and this might account for our
higher mortality rate. Although a potential weakness could
be variability between physicians and institutions, AORTA
registry data reveals that the general tendency of out-
comes is the same [1]. Although selection bias may skew
towards REBOA more than ACC in both AORTA and this
study, we feel that our results are worth consideration to
add to the scarce body of knowledge regarding this topic.
Moreover, we did not have detailed data on REBOA or
ACC such as the clamping time, the ballooning time,
and the tactics of that therapy. Since the patients had
the issue of ischemia/reperfusion injury, their out-
come may have been influenced by time. A general
assumption, however, is that clamping and ballooning
times were kept as short as possible by the physicians
because of the common knowledge that occlusion
times should be kept to a minimum.
Conclusions
Despite any residual indication bias, REBOA might be a
favorable alternative method to ACC, especially for severe
trauma below the diaphragm. Further study is needed to
elucidate optimal indications.
Key messages
 Patients who underwent AO had a high mortality.
 REBOA might be a favorable alternative method
to ACC.
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